APO RESEARCH · REPORT
GABA
GABA (γ-aminobutyric acid), CAS 56-12-2, is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.
Product & engineering
Understand the product.
GABA (γ-aminobutyric acid), CAS 56-12-2, is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.
Selected research
Industry Research
GABA Industry Research Report 2026
Market perspective
GABA (γ-aminobutyric acid), CAS 56-12-2, is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.
Global GABA (CAS 56-12-2) key players include Pharma Foods International, Kyowa Hakko, Sekisui Chemical, Sino Biotek, Zhejiang Yiwan Bio, etc. Global top five manufacturers hold a share about 45%. China is the largest market, with a share about 90%, followed by Japan, have a share over 3 percent. In terms of Production, Microbial Fermentation (feed grade) is the largest segment, with a share over 77%. And in terms of Application, the largest application is Food, followed by Medicine, Plant Growth Promoter, etc.
Report Scope
Read the full market overview
This report quantifies the global GABA market in revenue (US$ million) and, where applicable, sales volume (Ton), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Ton) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to GABA.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
GABA Market by Company
Pharma Foods International
Kyowa Hakko
Sekisui Chemical
Sino Biotek
Zhejiang Yiwan Bio
Shanghai Richen
Luckerkong
Qandr Biology
Bloomage Biotech
Jyswkj
Zjtr Chemistry
Xinyou Chemistry
Bornsun Biology
Huarui Biology
Viab Life
Microbiofeed
Harworld
GABA Segment by Type
Microbial Fermentation (Feed Grade)
Microbial Fermentation (Food Grade)
Chemical Synthesis
GABA Segment by Application
Animal Feed
Food
Medicine
Plant Growth Promoter
Cosmetic
Other
GABA Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GABA and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABA.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of GABA manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of GABA by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of GABA in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Microbial Fermentation (Feed Grade)
- Microbial Fermentation (Food Grade)
- Chemical Synthesis
Applications
- Animal Feed
- Food
- Medicine
- Plant Growth Promoter
- Cosmetic
- Other
Companies covered
- Pharma Foods International
- Kyowa Hakko
- Sekisui Chemical
- Sino Biotek
- Zhejiang Yiwan Bio
- Shanghai Richen
- Luckerkong
- Qandr Biology
- Bloomage Biotech
- Jyswkj
- Zjtr Chemistry
- Xinyou Chemistry
- Bornsun Biology
- Huarui Biology
- Viab Life
- Microbiofeed
- Harworld
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 GABA by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Microbial Fermentation (Feed Grade)
- 2.2.3 Microbial Fermentation (Food Grade)
- 2.2.4 Chemical Synthesis
- 2.3 GABA by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Animal Feed
- 2.3.3 Food
- 2.3.4 Medicine
- 2.3.5 Plant Growth Promoter
- 2.3.6 Cosmetic
- 2.3.7 Other
- 2.4 Global Market Growth Prospects
- 2.4.1 Global GABA Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global GABA Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global GABA Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global GABA Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global GABA Production by Manufacturers (2021-2026)
- 3.2 Global GABA Production Value by Manufacturers (2021-2026)
- 3.3 Global GABA Average Price by Manufacturers (2021-2026)
- 3.4 Global GABA Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global GABA Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global GABA Manufacturers, Product Type & Application
- 3.7 Global GABA Manufacturers Established Date
- 3.8 Global GABA Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pharma Foods International
- 4.1.1 Pharma Foods International GABA Company Information
- 4.1.2 Pharma Foods International GABA Business Overview
- 4.1.3 Pharma Foods International GABA Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Pharma Foods International Product Portfolio
- 4.1.5 Pharma Foods International Recent Developments
- 4.2 Kyowa Hakko
- 4.2.1 Kyowa Hakko GABA Company Information
- 4.2.2 Kyowa Hakko GABA Business Overview
- 4.2.3 Kyowa Hakko GABA Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Kyowa Hakko Product Portfolio
- 4.2.5 Kyowa Hakko Recent Developments
- 4.3 Sekisui Chemical
- 4.3.1 Sekisui Chemical GABA Company Information
- 4.3.2 Sekisui Chemical GABA Business Overview
- 4.3.3 Sekisui Chemical GABA Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Sekisui Chemical Product Portfolio
- 4.3.5 Sekisui Chemical Recent Developments
- 4.4 Sino Biotek
- 4.4.1 Sino Biotek GABA Company Information
- 4.4.2 Sino Biotek GABA Business Overview
- 4.4.3 Sino Biotek GABA Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Sino Biotek Product Portfolio
- 4.4.5 Sino Biotek Recent Developments
- 4.5 Zhejiang Yiwan Bio
- 4.5.1 Zhejiang Yiwan Bio GABA Company Information
- 4.5.2 Zhejiang Yiwan Bio GABA Business Overview
- 4.5.3 Zhejiang Yiwan Bio GABA Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Zhejiang Yiwan Bio Product Portfolio
- 4.5.5 Zhejiang Yiwan Bio Recent Developments
- 4.6 Shanghai Richen
- 4.6.1 Shanghai Richen GABA Company Information
- 4.6.2 Shanghai Richen GABA Business Overview
- 4.6.3 Shanghai Richen GABA Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Shanghai Richen Product Portfolio
- 4.6.5 Shanghai Richen Recent Developments
- 4.7 Luckerkong
- 4.7.1 Luckerkong GABA Company Information
- 4.7.2 Luckerkong GABA Business Overview
- 4.7.3 Luckerkong GABA Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Luckerkong Product Portfolio
- 4.7.5 Luckerkong Recent Developments
- 4.8 Qandr Biology
- 4.8.1 Qandr Biology GABA Company Information
- 4.8.2 Qandr Biology GABA Business Overview
- 4.8.3 Qandr Biology GABA Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Qandr Biology Product Portfolio
- 4.8.5 Qandr Biology Recent Developments
- 4.9 Bloomage Biotech
- 4.9.1 Bloomage Biotech GABA Company Information
- 4.9.2 Bloomage Biotech GABA Business Overview
- 4.9.3 Bloomage Biotech GABA Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Bloomage Biotech Product Portfolio
- 4.9.5 Bloomage Biotech Recent Developments
- 4.10 Jyswkj
- 4.10.1 Jyswkj GABA Company Information
- 4.10.2 Jyswkj GABA Business Overview
- 4.10.3 Jyswkj GABA Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Jyswkj Product Portfolio
- 4.10.5 Jyswkj Recent Developments
- 4.11 Zjtr Chemistry
- 4.11.1 Zjtr Chemistry GABA Company Information
- 4.11.2 Zjtr Chemistry GABA Business Overview
- 4.11.3 Zjtr Chemistry GABA Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Zjtr Chemistry Product Portfolio
- 4.11.5 Zjtr Chemistry Recent Developments
- 4.12 Xinyou Chemistry
- 4.12.1 Xinyou Chemistry GABA Company Information
- 4.12.2 Xinyou Chemistry GABA Business Overview
- 4.12.3 Xinyou Chemistry GABA Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Xinyou Chemistry Product Portfolio
- 4.12.5 Xinyou Chemistry Recent Developments
- 4.13 Bornsun Biology
- 4.13.1 Bornsun Biology GABA Company Information
- 4.13.2 Bornsun Biology GABA Business Overview
- 4.13.3 Bornsun Biology GABA Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 Bornsun Biology Product Portfolio
- 4.13.5 Bornsun Biology Recent Developments
- 4.14 Huarui Biology
- 4.14.1 Huarui Biology GABA Company Information
- 4.14.2 Huarui Biology GABA Business Overview
- 4.14.3 Huarui Biology GABA Production Capacity, Value and Gross Margin (2021-2026)
- 4.14.4 Huarui Biology Product Portfolio
- 4.14.5 Huarui Biology Recent Developments
- 4.15 Viab Life
- 4.15.1 Viab Life GABA Company Information
- 4.15.2 Viab Life GABA Business Overview
- 4.15.3 Viab Life GABA Production Capacity, Value and Gross Margin (2021-2026)
- 4.15.4 Viab Life Product Portfolio
- 4.15.5 Viab Life Recent Developments
- 4.16 Microbiofeed
- 4.16.1 Microbiofeed GABA Company Information
- 4.16.2 Microbiofeed GABA Business Overview
- 4.16.3 Microbiofeed GABA Production Capacity, Value and Gross Margin (2021-2026)
- 4.16.4 Microbiofeed Product Portfolio
- 4.16.5 Microbiofeed Recent Developments
- 4.17 Harworld
- 4.17.1 Harworld GABA Company Information
- 4.17.2 Harworld GABA Business Overview
- 4.17.3 Harworld GABA Production Capacity, Value and Gross Margin (2021-2026)
- 4.17.4 Harworld Product Portfolio
- 4.17.5 Harworld Recent Developments
5 Global GABA Production by Region
- 5.1 Global GABA Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global GABA Production by Region: 2021-2032
- 5.2.1 Global GABA Production by Region: 2021-2026
- 5.2.2 Global GABA Production Forecast by Region (2027-2032)
- 5.3 Global GABA Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global GABA Production Value by Region: 2021-2032
- 5.4.1 Global GABA Production Value by Region: 2021-2026
- 5.4.2 Global GABA Production Value Forecast by Region (2027-2032)
- 5.5 Global GABA Market Price Analysis by Region (2021-2026)
- 5.6 Global GABA Production and Value, YOY Growth
- 5.6.1 North America GABA Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe GABA Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China GABA Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan GABA Production Value Estimates and Forecasts (2021-2032)
6 Global GABA Consumption by Region
- 6.1 Global GABA Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global GABA Consumption by Region (2021-2032)
- 6.2.1 Global GABA Consumption by Region: 2021-2026
- 6.2.2 Global GABA Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America GABA Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America GABA Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe GABA Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe GABA Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific GABA Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific GABA Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa GABA Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa GABA Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global GABA Production by Type (2021-2032)
- 7.1.1 Global GABA Production by Type (2021-2032) & (Ton)
- 7.1.2 Global GABA Production Market Share by Type (2021-2032)
- 7.2 Global GABA Production Value by Type (2021-2032)
- 7.2.1 Global GABA Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global GABA Production Value Market Share by Type (2021-2032)
- 7.3 Global GABA Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global GABA Production by Application (2021-2032)
- 8.1.1 Global GABA Production by Application (2021-2032) & (Ton)
- 8.1.2 Global GABA Production Market Share by Application (2021-2032)
- 8.2 Global GABA Production Value by Application (2021-2032)
- 8.2.1 Global GABA Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global GABA Production Value Market Share by Application (2021-2032)
- 8.3 Global GABA Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 GABA Value Chain Analysis
- 9.1.1 GABA Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 GABA Production Mode & Process
- 9.2 GABA Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 GABA Distributors
- 9.2.3 GABA Customers
10 Global GABA Analyzing Market Dynamics
- 10.1 GABA Industry Trends
- 10.2 GABA Industry Drivers
- 10.3 GABA Industry Opportunities and Challenges
- 10.4 GABA Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst